Subcutaneous tocilizumab in patients with rheumatoid arthritis; a high number of patients achieve doppler remission after 24 weeks

H B Hammer, I M J Hansen, P Jarvinen, M Leirisalo-Repo, M Ziegelasch, B Agular, Lene Terslev

Original language	English
Article number	THU0200
Journal	Annals of the Rheumatic Diseases
Volume	77
Issue number	Suppl. 2
Pages (from-to)	319
Number of pages	1
ISSN	0003-4967
Publication status	Published - 2018

Cite this

@article{f93f5c3a5bad47dca2d12af3cad29bb0,

title = "Subcutaneous tocilizumab in patients with rheumatoid arthritis; a high number of patients achieve doppler remission after 24 weeks",

author = "Hammer, \{H B\} and Hansen, \{I M J\} and P Jarvinen and M Leirisalo-Repo and M Ziegelasch and B Agular and Lene Terslev",

note = "COPECARE",

year = "2018",

language = "English",

volume = "77",

pages = "319",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "Elsevier BV",

number = "Suppl. 2",

}

TY - ABST

T1 - Subcutaneous tocilizumab in patients with rheumatoid arthritis; a high number of patients achieve doppler remission after 24 weeks

AU - Hammer, H B

AU - Hansen, I M J

AU - Jarvinen, P

AU - Leirisalo-Repo, M

AU - Ziegelasch, M

AU - Agular, B

AU - Terslev, Lene

N1 - COPECARE

PY - 2018

Y1 - 2018

M3 - Conference abstract in journal

SN - 0003-4967

VL - 77

SP - 319

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl. 2

M1 - THU0200

ER -